Cantel Medical Corp. (N:CMD)

Business Focus: Medical Equipment Wholesale

Show only public market trades

Competitors with Recent Insider Filings

Merit Medical Systems (OQ:MMSI)

Henry Schein (OQ:HSIC)

Owens & Minor (N:OMI)

Latest 10 SEC filings (by transaction date) for CMD within the last 6 months	[?]
Amended Filing Footnote and/or Remark

					As of
Filing Date	Transaction Date	Insider Name	Ownership Type	Securities	Nature of transaction	# or value acquired or disposed of	Price
Aug 10/18	Jul 31/18	Evnin Anthony B	Direct Ownership	Common Stock, par value $.10 per share	A - Grant, award or other under Rule 16b-3(d)	712
Aug 2/18	Jul 31/18	Myers Ronnie	Direct Ownership	Common Stock, par value $.10 per share	A - Grant, award or other under Rule 16b-3(d)	712
Aug 2/18	Jul 31/18	Fotiades George L	Direct Ownership	Common Stock, par value $.10 per share	A - Grant, award or other under Rule 16b-3(d)	712
Aug 2/18	Jul 31/18	Diker Mark N.	Direct Ownership	Common Stock, par value $.10 per share	A - Grant, award or other under Rule 16b-3(d)	712
Aug 2/18	Jul 31/18	Pronovost Peter	Direct Ownership	Common Stock, par value $.10 per share	A - Grant, award or other under Rule 16b-3(d)	712
Aug 2/18	Jul 31/18	Berman Ann E	Direct Ownership	Common Stock, par value $.10 per share	A - Grant, award or other under Rule 16b-3(d)	712
Aug 2/18	Jul 31/18	Forese Laura L	Direct Ownership	Common Stock	A - Grant, award or other under Rule 16b-3(d)	712
Aug 2/18	Jul 31/18	Batkin Alan R	Direct Ownership	Common Stock, par value $.10 per share	A - Grant, award or other under Rule 16b-3(d)	712
Jul 9/18	Jul 6/18	Myers Ronnie	Direct Ownership	Common Stock, par value $.10 per share	S - Open market or private sale	-261	$95.72
May 16/18	May 15/18	Nodiff Eric W	Direct Ownership	Common Stock, par value $.10 per share	F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3	-2,197	$124.47
Sign up for a free account or login above to see all SEC filings within the past 6 months. During our beta offer, get free access to company PDF reports.

Latest 10 SEC filings (by filing date) for CMD within the last 6 months	[?]
Amended Filing Footnote and/or Remark

					As of
Filing Date	Transaction Date	Insider Name	Ownership Type	Securities	Nature of transaction	# or value acquired or disposed of	Price
Aug 10/18	Jul 31/18	Evnin Anthony B	Direct Ownership	Common Stock, par value $.10 per share	A - Grant, award or other under Rule 16b-3(d)	712
Aug 2/18	Jul 31/18	Myers Ronnie	Direct Ownership	Common Stock, par value $.10 per share	A - Grant, award or other under Rule 16b-3(d)	712
Aug 2/18	Jul 31/18	Fotiades George L	Direct Ownership	Common Stock, par value $.10 per share	A - Grant, award or other under Rule 16b-3(d)	712
Aug 2/18	Jul 31/18	Diker Mark N.	Direct Ownership	Common Stock, par value $.10 per share	A - Grant, award or other under Rule 16b-3(d)	712
Aug 2/18	Jul 31/18	Pronovost Peter	Direct Ownership	Common Stock, par value $.10 per share	A - Grant, award or other under Rule 16b-3(d)	712
Aug 2/18	Jul 31/18	Berman Ann E	Direct Ownership	Common Stock, par value $.10 per share	A - Grant, award or other under Rule 16b-3(d)	712
Aug 2/18	Jul 31/18	Forese Laura L	Direct Ownership	Common Stock	A - Grant, award or other under Rule 16b-3(d)	712
Aug 2/18	Jul 31/18	Batkin Alan R	Direct Ownership	Common Stock, par value $.10 per share	A - Grant, award or other under Rule 16b-3(d)	712
Jul 9/18	Jul 6/18	Myers Ronnie	Direct Ownership	Common Stock, par value $.10 per share	S - Open market or private sale	-261	$95.72
May 16/18	May 15/18	Nodiff Eric W	Direct Ownership	Common Stock, par value $.10 per share	F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3	-2,197	$124.47
Sign up for a free account or login above to see all SEC filings within the past 6 months. During our beta offer, get free access to company PDF reports.

Sign up for a free account or login above to see the past 6 months of filings sorted by insider. During our beta offer, get free access to company PDF reports.

Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $CMD

View on Twitter

StockTwits

Disclaimer :: Use of this site is subject to, and your continued use constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is strictly prohibited. Insidertracking.com is operated by INK Research Corp (INK). INK provides general information. INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion; however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion expressed herein is subject to change without notice. Insider information is based on filings made either on EDGAR® or on the System for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment. Users should always consult with and obtain advice from their professional licensed financial advisor, including their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment or trading securities do so with caution. Users should perform full due diligence and investigate any security fully before making an investment or before the execution of a security trade based upon information learned through INK. Investors should obtain annual reports and other company information to complete their own due diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this website. On this site, there may be third party content, content from authors or links to third-party sites or pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI® is a registered trade-mark owned by the Alberta Securities Commission. Copyright © 2018 INK Research Corp. All rights reserved.

US Quotes Data provided for free by IEX

North American company fundamental and Canadian price data sourced from © Thomson Reuters Limited. All rights reserved. Republication or redistribution of Thomson Reuters content, including by framing or similar means, is prohibited without the prior written consent of Thomson Reuters. Thomson Reuters is not liable for any errors or delays in Thomson Reuters content, or for any actions taken in reliance on such content. 'Thomson Reuters' and the Thomson Reuters logo are trademarks of Thomson Reuters and its affiliated companies.